Boosting mammalian cell-line manufacturing pilot plant: A case report

BioPharm International

Volumn 18, Issue 7, 2005, Pages 22-30

  Bretht, Rene ^a   Sandig, Volker ^b   Koch, Susann ^b   Marx, Uwe ^b   Riedel, Marco ^b  

^a PROBIOGEN AG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; CYTOKINE; GLYCOPROTEIN; HYBRID PROTEIN; MONOCLONAL ANTIBODY; OKT 3; PROTEINASE INHIBITOR;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; BIOREACTOR; CELL LINE; DISPOSABLE EQUIPMENT; DRUG LEGISLATION; EUROPEAN UNION; HOLLOW FIBER REACTOR; MAMMAL CELL; MARKET; NANOFILTRATION; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PRODUCTIVITY;

EID: 23244443951     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Melmer G, Biopharmaceuticals and the industrial environment. In. G. Gelissen: Production of recombinant proteins. Wiley-VCH, 2005; 361-383.
2. www.synthecon.com.
3. www.nuncbrand.com.
4. www.wavebiotech.com.
5. www.biovest.com.
6. Sandig V, Rose Th, Winkler K, Brecht R: Mammalian cells. In. G. Gelissen: Production of recombinant proteins. Wiley-VCH, 2005; 233-252.
7. Nagel A, Koch S, Valley U, Emmrich F, Marx U: Membrane based cell culture systems - an alternative to in vivo production of monoclonal antibodies. Dev. Biol. Stand., Karger, 1999; 101:57-64.
8. Yalcin E, Kloth C, Buchholz R, Emmrich F, Harnisch J, Lemke U, Gerlach J, Marx U: Increased production yields of native interferon-gamma in membrane bioreactors by continuous harvest. 2001, proceedings of ESACT meeting.
9. Xie LZ, Wang DIC, High cell - density and monoclonal antibody production through medium design and rational control in a bioreactor. Biotechnol Bioeng. 1996; 51:725-729.
10. Zhou WC, Chen CC, Buckland B, Aunins J: Fed batch culture of recombinant NSO myeloma cells with high monoclonal antibody production. Biotech Bioeng. 1997; 783-792.
11. Sauer PW, Burky JE, Wesson MC, Sternard HD, Qu LA. A High-Yielding, Generic Fed-Batch Cell Culture Process for Production of Recombinant Antibodies, Biotechnol Bioeng. 2000 March 5; 67(5):585-97.
12. Davies J, Reff M. Chromosome localization and gene-copy-number quantification of three random integrations in Chinese-hamster ovary cells and their amplified cell lines using fluorescence in situ hybridization; Biotechnol. Appl. Biochem. (2001); 33:99-105.
13. Sauer P et al. Optimization of a fed-batch process producing humanized antibodies: increasing product. PDL, Poster presentation ESACT Congress, 2003.
14. Rendall M. et al., Transfection to manufacturing: reducing timelines for high yielding GS-CHO processes, Lonza, poster presentation, ESACT Congress, 2003.
15. Deeds ZW, et al. Creating a new medium to help meet the variable nutritional requirements of Chinese hamster ovary (CHO) cell clones, Sigma-Aldrich Biotechnology, poster presentation, ESACT Congress, 2003.
16. Sautter K, Fieder J, Otto R, Enenkel B, HTS based development of high producing CHO cell lines, Boehringer Ingelheim, poster presentation, ESACT Congress, 2003.
17. Talabardon M, Ong M, Rahmati S, Chang DYH, Noe W. Phase I process development for monoclonal antibody production. IDEC Pharmaceuticals, poster presentation, ESACT Congress, 2003.
18. Wang M-D., Yang, M, Huzel, N, Butler B. Erythropoietin production from CHO cells grown by continuous culture in a fluidized-bed bioreactor. Biotechnology and Bioengineering, 2002; 77(2):194-203.
19. Wurm, F. Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology, 2004; 22(11):1393-1397.
20. Monge M, Hammarberg B. The Biomanufacturing Concept Facility. The Modular approach combined with single - use technology. bioLOGIC, 2004; Geneva 22-24 June (combined oral presentation of Stedim and Applicon).
21. Sinclair A, Monge M. Quantitative economic evaluation of single use disposables in bioprocessing. Pharmaceutical Engineering 2002; 22 (3):20-34.
22. Hodge G. Disposable Components enable a new approach to biopharmaceutical manufacturing, BioPharm International 2004; 17 (3):38-49.